Task: Answer the multiple-choice question.
Question: Which compound exhibits a -58.236% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
[a] COc1cc(N=Nc2c(C)n(C)n(-c3ccccc3)c2=O)ccc1N
[b] Nc1oc2ccc(F)cc2c(=O)c1C=O
[c] COc1ccc(C(=O)O/N=C(\C)c2cnccn2)cc1
[d] CCC(CC)CN1C(Nc2ccccc2)=NC[C@@H]1CC(C)C
Answer: d. CCC(CC)CN1C(Nc2ccccc2)=NC[C@@H]1CC(C)C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(CC)CN1C(Nc2ccccc2)=NC[C@@H]1CC(C)C
CCC(CC)CN1C(Nc2ccccc2)=NC[C@@H]1CC(C)C
(5S)-1-(2-ethylbutyl)-5-(2-methylpropyl)-N-phenyl-4,5-dihydroimidazol-2-amine